Source: Sensus Blog

Sensus Blog Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

BOCA RATON, Fla. - Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report financial results for the first quarter of 2025 on Thursday, May 15, 2025. Management will hold a conference call beginning at 4:30 [...]The post Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15 appeared first on Sensus Healthcare.

Read full article »
Annual Revenue
$25-100M
Employees
25-100
Joseph C. Sardano's photo - Chairman & CEO of Sensus

Chairman & CEO

Joseph C. Sardano

CEO Approval Rating

87/100

Read more